Cresco Labs (CRLBF) Liabilities from Discontinued Operations (2023 - 2025)

Cresco Labs (CRLBF) posted Liabilities from Discontinued Operations of 4975000.0 for Q3 2025, down 6.19% on a QoQ basis from 5303000.0 in Q2 2025.

Cresco Labs (CRLBF) Liabilities from Discontinued Operations (2023 - 2025) Analysis & Trends

Cresco Labs' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 4975000.0 for Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Cresco Labs	254.96 Mn	99.57 Mn	75.45 Mn

Download Data